WebDisclosure WebDisclosure
Basculer en Français
9903 Companies
199499 Keywords
130354 Articles
106023 Press releases
Headlines Articles Press releases MDBriefCase Remove
  1. Home
  2. Companies
  3. MDBriefCase
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/25/2024 at 15:05, 1 year 4 months ago

    MDBriefCase Announces Relaunch of RxBriefCase for Pharmacists

    Pharmapod Continuing Education RxBriefCase Pharmacists MDBriefCase
  • BRIEF

    published on 09/25/2024 at 15:05, 1 year 4 months ago

    MDBriefCase annonce le lancement de RxBriefCase pour les pharmaciens

    Pharmapod Formation Continue MDBriefCase Mallette Rx Pharmaciens
  • PRESS RELEASE

    published on 09/25/2024 at 15:00, 1 year 4 months ago

    MDBriefCase Announces Relaunch of RxBriefCase, a Leading Continuing Education Platform for Pharmacists

    MDBriefCase announces relaunch of RxBriefCase in partnership with Pharmapod, offering accredited pharmacy courses for professional development. Platform emphasizes safety, innovation, and accessibility for pharmacists
    Professional Development Pharmapod RxBriefCase MDBriefCase Pharmacy Courses
    Logo of MDBriefCase
Accesswire
  • Published on 02/20/2026 at 15:45, 1 hour 22 minutes ago

    Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway

  • Published on 02/20/2026 at 14:30, 2 hours 37 minutes ago

    Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant

  • Published on 02/20/2026 at 14:08, 2 hours 59 minutes ago

    Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange

  • Published on 02/20/2026 at 14:00, 3 hours 7 minutes ago

    Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

  • Published on 02/20/2026 at 13:30, 3 hours 37 minutes ago

    ESGold Launches 70 km2 District-Scale ANT Survey at Montauban Following 3D Model Identifying Deep, Expanding 2 km Mineralized Corridor

View all ACCESSWIRE
EQS Group
  • Published on 02/20/2026 at 16:38, 28 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 02/20/2026 at 15:25, 1 hour 42 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: JTC plc

  • Published on 02/20/2026 at 15:24, 1 hour 42 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Beazley plc

  • Published on 02/20/2026 at 15:23, 1 hour 43 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

  • Published on 02/20/2026 at 15:23, 1 hour 44 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc

View all EQS
Les Echos
  • Published on 02/20/2026 at 09:28, 7 hours 39 minutes ago

    Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026

  • Published on 02/20/2026 at 09:28, 7 hours 39 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026

  • Published on 02/20/2026 at 07:30, 9 hours 37 minutes ago

    Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan

  • Published on 02/20/2026 at 07:30, 9 hours 37 minutes ago

    Announcement of share buyback in the context of a share purchase plan

  • Published on 02/20/2026 at 07:30, 9 hours 37 minutes ago

    Announcement of share buyback in the context of a share purchase plan

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy